Showing results (111-120 of 1,627) with videos related to

Sort By:
Pageof 163
The International Journal of Biological Markers|March 3, 2022
A meta-analysis of the platelet-lymphocyte ratio: A notable prognostic factor in renal cell carcinomaXiao Zhou, Guangcheng Luo
The International Journal of Biological Markers|May 26, 2018
Deciphering the potential value of 5-fluorouracil metabolic enzymes in predicting prognosis and treatment response of colorectal cancer patientsKinjal K Gajjar, Hemangini H Vora, Toral P Kobawala, et al.
The International Journal of Biological Markers|March 18, 1999
How tumor markers are used in the routine follow-up of breast and colorectal cancer. A survey of 29 Italian hospitalsM Gion, P Barioli, A Ponti, et al.
The International Journal of Biological Markers|March 18, 1999
Dehydroepiandrosterone sulfate (DHEAS) secretion in early and advanced solid neoplasms: selective deficiency in metastatic diseaseP Lissoni, F Rovelli, L Giani, et al.
The International Journal of Biological Markers|March 18, 1999
Preoperative carbohydrate antigen 195 (CA195) and CEA serum levels as prognostic factors in patients with colorectal cancerA Andicoechea, F Vizoso, E Alexandre, et al.
The International Journal of Biological Markers|March 18, 1999
Gonadotropin levels in ovarian cyst fluids: a predictor of malignancy?S Krämer, M Leeker, W Jäger
The International Journal of Biological Markers|November 24, 1999
CD30/CD30 ligand and CD40/CD40 ligand in malignant lymphoid disordersA Younes, A Carbone
The International Journal of Biological Markers|November 24, 1999
Blood concentrations of tumor necrosis factor-alpha in malignant lymphomas and their decrease as a predictor of disease control in response to low-dose subcutaneous immunotherapy with interleukin-2P Lissoni, S Bolis, M Mandalà, et al.
The International Journal of Biological Markers|November 24, 1999
Immunometric assays of ras and c-erbB-2/neu overexpression in breast cancer: a pilot studyD Pelizzola, R Malagutti, G Giovannini, et al.
The International Journal of Biological Markers|June 15, 1999
Review of clinical studies of CA 27.29 in breast cancer managementR A Beveridge
Pageof 163